John Chou - Cencora Ex CEO

COR Stock  USD 251.55  1.86  0.74%   

CEO

John Chou is Ex CEO of Cencora
Age 68
Address 1 West First Avenue, Conshohocken, PA, United States, 19428-1800
Phone610 727 7000
Webhttps://www.cencora.com

Cencora Management Efficiency

The company has Return on Asset of 0.031 % which means that on every $100 spent on assets, it made $0.031 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.0912 %, implying that it generated $2.0912 on every 100 dollars invested. Cencora's management efficiency ratios could be used to measure how well Cencora manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cencora's Return On Tangible Assets are relatively stable compared to the past year. As of 11/29/2024, Return On Assets is likely to grow to 0.02, while Return On Capital Employed is likely to drop 0.15. At this time, Cencora's Return On Assets are relatively stable compared to the past year. As of 11/29/2024, Asset Turnover is likely to grow to 5.17, while Intangible Assets are likely to drop slightly above 2.7 B.
Cencora has 4.39 B in debt. Cencora has a current ratio of 0.57, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Cencora to invest in growth at high rates of return.

Similar Executives

Found 6 records

CEO Age

John TurnerGMS Inc
55
Peter SteenkampHarmony Gold Mining
64
James BrockConsol Energy
67
Johannes HeerdenHarmony Gold Mining
47
Robert MehmelGriffon
62
Adolfo RivasGrupo Aeroportuario del
60
CoreSite Realty Corporation delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. Our scalable, flexible solutions and 460 dedicated employees consistently deliver unmatched data center options all of which leads to a best-in-class customer experience and lasting relationships. Coresite Realty operates under REITSpecialty classification in the United States and is traded on New York Stock Exchange. It employs 480 people. Cencora (COR) is traded on New York Stock Exchange in USA. It is located in 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 and employs 46,000 people. Cencora is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Cencora Leadership Team

Elected by the shareholders, the Cencora's board of directors comprises two types of representatives: Cencora inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cencora. The board's role is to monitor Cencora's management team and ensure that shareholders' interests are well served. Cencora's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cencora's outside directors are responsible for providing unbiased perspectives on the board's policies.
PharmD Mauch, CEO, President
Michael Millegan, Independent Director
James Cleary, Executive CFO
Elizabeth JD, Executive Officer
Bennett Murphy, Senior Relations
Maile Kaiser, Senior Vice President of Sales
John Chou, Ex CEO
Pawan Verma, Chief VP
Jeffrey Finnin, Chief Financial Officer
Derek McCandless, Senior Vice President - Legal, General Counsel, Secretary
David Wilson, Lead Independent Director
Elizabeth Campbell, Executive Officer
Silvana Battaglia, Executive Officer
Leslie Donato, Executive Officer
Lazarus Krikorian, Chief VP
Robert Stuckey, Independent Chairman of the Board
J Quinn, VP Treasurer
James Attwood, Independent Director
John Thompson, Independent Director
Aleksandra Krusko, Senior Vice President Information Technology
Steven Collis, President Chairman
Anthony Hatzenbuehler, Senior Vice President Data Center Operations
Jean Bua, Independent Director
Michael Koehler, Independent Director
Paul Szurek, President, Chief Executive Officer, Director
Ann Anaya, Senior Officer
Richard Tremonte, EVP Pharmaceuticals
Gina Clark, Executive Officer
Juan Font, Senior Vice President - General Management
Jennifer Dubas, Senior Officer
Brian Warren, Senior Vice President - Development and Product Engineering
Kelly Chambliss, Independent Director
Kathy Gaddes, Ex Officer
Patricia Higgins, Independent Director
Steven Smith, Sr. VP of Sales and Marketing
RPh Nightengale, President Pharmacy

Cencora Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cencora a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Cencora

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cencora position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cencora will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cencora Stock

  0.75GH Guardant HealthPairCorr
  0.81LH LaboratoryPairCorr

Moving against Cencora Stock

  0.72DRIO DarioHealth CorpPairCorr
  0.48VERO Venus ConceptPairCorr
The ability to find closely correlated positions to Cencora could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cencora when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cencora - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cencora to buy it.
The correlation of Cencora is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cencora moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cencora moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cencora can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Cencora Stock Analysis

When running Cencora's price analysis, check to measure Cencora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cencora is operating at the current time. Most of Cencora's value examination focuses on studying past and present price action to predict the probability of Cencora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cencora's price. Additionally, you may evaluate how the addition of Cencora to your portfolios can decrease your overall portfolio volatility.